ArticleJournal of the American Academy of DermatologyPublished
Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of the American Academy of Dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Psoriasis; Adults; Withdrawal; Retreatment; Responder; Oral Peptide; Icotrokinra; Iconic-lead
- PubMed ID
- 42176706
- Added to directory
- Source checked